Cargando…

Venous thrombosis recurrence risk according to warfarin versus direct oral anticoagulants for the secondary prevention of venous thrombosis

BACKGROUND: Venous thromboembolism (VTE) affects nearly 1 million Americans annually, and many benefit from continued anticoagulation after the initial 3‐ to 6‐month treatment period (secondary prevention). OBJECTIVES: To determine whether warfarin, apixaban, or rivaroxaban is associated with reduce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zakai, Neil A., Walker, Rob F., MacLehose, Richard F., Koh, Insu, Alonso, Alvaro, Lutsey, Pamela L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8371351/ https://www.ncbi.nlm.nih.gov/pubmed/34430789 http://dx.doi.org/10.1002/rth2.12575

Ejemplares similares

Direct oral anticoagulants and warfarin for venous thromboembolism treatment: Trends from 2012 to 2017
por: Lutsey, Pamela L., et al.
Publicado: (2019)

Impact of oral anticoagulant choice for the secondary prevention of venous thromboembolism on the risk of inpatient bleeding
por: MacLehose, Richard F., et al.
Publicado: (2021)

Claims‐Based Score for the Prediction of Bleeding in a Contemporary Cohort of Patients Receiving Oral Anticoagulation for Venous Thromboembolism
por: Alonso, Alvaro, et al.
Publicado: (2021)

Autoimmune disease and risk of postpartum venous thromboembolism
por: Walker, Rob F., et al.
Publicado: (2023)

Inpatient Versus Outpatient Acute Venous Thromboembolism Management: Trends and Postacute Healthcare Utilization From 2011 to 2018
por: Lutsey, Pamela L., et al.
Publicado: (2021)

Incidence and Risk Factors of Pulmonary Hypertension After Venous Thromboembolism: An Analysis of a Large Health Care Database
por: Lutsey, Pamela L., et al.
Publicado: (2022)

Venous thrombosis risk during and after medical and surgical hospitalizations: The medical inpatient thrombosis and hemostasis (MITH) study
por: Jordan Bruno, Ximena, et al.
Publicado: (2022)

A new model to predict major bleeding in patients with atrial fibrillation using warfarin or direct oral anticoagulants
por: Claxton, J’Neka S., et al.
Publicado: (2018)

Epidemiology and prevention of venous thromboembolism
por: Lutsey, Pamela L., et al.
Publicado: (2022)

The Role of Warfarin and Rivaroxaban in the Treatment of Cerebral Venous Thrombosis
por: Fayyaz, Muniba, et al.
Publicado: (2019)

Anticoagulant Preferences and Concerns among Venous Thromboembolism Patients
por: Lutsey, Pamela L., et al.
Publicado: (2018)

Weight change over 9 years and subsequent risk of venous thromboembolism in the ARIC cohort.
por: French, Simone A., et al.
Publicado: (2020)

Association of Type of Antidepressant Initiation with Bleeding Risk in Atrial Fibrillation Patients Taking Oral Anticoagulants
por: Shao, Iris Yuefan, et al.
Publicado: (2021)

Efficacy and risks of anticoagulation for cerebral venous thrombosis
por: Xu, Weilin, et al.
Publicado: (2018)

New Oral Anticoagulants versus Warfarin for Cerebral Venous Thrombosis: A Multi-Center, Observational Study
por: Wasay, Mohammad, et al.
Publicado: (2019)

Comparative effectiveness of rivaroxaban versus warfarin or dabigatran for the treatment of patients with non-valvular atrial fibrillation
por: Norby, Faye L., et al.
Publicado: (2017)

Long-term Anticoagulation with Apixaban in Patients with Cerebral Venous Thrombosis
por: Bharath, Suman Preet, et al.
Publicado: (2023)

Causes of venous thrombosis
por: Rosendaal, F. R.
Publicado: (2016)

Venous Thrombosis
Publicado: (1901)

Venous Thrombosis
por: Mitchell, J. R. A.
Publicado: (1988)

Recurrent venous thrombosis in an adequately anticoagulated patient with pemphigus vulgaris
por: Ames, Paul R. J., et al.
Publicado: (2016)

Anticoagulant approach in COVID-19 patients with cerebral venous thrombosis
por: Kow, Chia Siang, et al.
Publicado: (2020)

Timing and Predictors of Recanalization After Anticoagulation in Cerebral Venous Thrombosis
por: Salehi Omran, Setareh, et al.
Publicado: (2023)

Quality of anticoagulant therapy and the incidence of in‐stent thrombosis after venous stenting
por: Notten, Pascale, et al.
Publicado: (2020)

Bleeding risk in patients with multiple myeloma treated for venous thromboembolism: a MarketScan analysis
por: Adrianzen-Herrera, Diego, et al.
Publicado: (2022)

The Treatment of Venous Thrombosis
Publicado: (1909)

Periprostatic venous thrombosis
por: Paulino, Eduardo, et al.
Publicado: (2016)

Venous thrombosis in neonates
por: Bhatt, Mihir D, et al.
Publicado: (2021)

Cerebral venous thrombosis
por: Moraes, Anisio Adalio de Azevedo, et al.
Publicado: (2022)

Epidemiology of recurrent venous thrombosis
por: Ribeiro, D.D., et al.
Publicado: (2011)

Shorter Hospital Stays and Lower Costs for Rivaroxaban Compared With Warfarin for Venous Thrombosis Admissions
por: Margolis, Jay M., et al.
Publicado: (2016)

Safety assessment of anticoagulation therapy in patients with hemorrhagic cerebral venous thrombosis
por: Ghandehari, Kavian, et al.
Publicado: (2013)

Cerebral venous sinus thrombosis in homocystinuria: Dietary intervention in conjunction with anticoagulation
por: Yap, Sufin, et al.
Publicado: (2017)

Anticoagulation delay does not affect the functional outcome of cerebral venous thrombosis
por: Ji, Kangxiang, et al.
Publicado: (2020)

Splanchnic Venous Thrombosis in Acute Pancreatitis: Does Anticoagulation Affect Outcome?
por: Junare, Parmeshwar Ramesh, et al.
Publicado: (2020)

Development of a computable phenotype using electronic health records for venous thromboembolism in medical inpatients: the Medical Inpatient Thrombosis and Hemostasis study
por: Thomas, Ryan M., et al.
Publicado: (2023)

Anticoagulant treatment satisfaction with warfarin and direct oral anticoagulants for venous thromboembolism
por: Fang, Margaret C., et al.
Publicado: (2021)

Cerebral venous sinus thrombosis secondary to neurocryptococcosis
por: Borella, Luiz Fernando Monte, et al.
Publicado: (2023)

Cerebral venous and sinus thrombosis
por: Boucelma, Malika
Publicado: (2013)

Cerebral sinus venous thrombosis
por: Alvis-Miranda, Hernando Raphael, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_dvvvl8lc9kvhj5vt9ebdak5aqb